- Home
- MPAA vs NMRA Comparison
MPAA vs NMRA Comparison
Compare MPAA & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPAA
- NMRA
- Stock Information
- Founded
- MPAA 1968
- NMRA 2019
- Country
- MPAA United States
- NMRA United States
- Employees
- MPAA N/A
- NMRA N/A
- Industry
- MPAA Auto Parts:O.E.M.
- NMRA
- Sector
- MPAA Consumer Discretionary
- NMRA
- Exchange
- MPAA Nasdaq
- NMRA Nasdaq
- Market Cap
- MPAA 281.2M
- NMRA 268.5M
- IPO Year
- MPAA 1994
- NMRA 2023
- Fundamental
- Price
- MPAA $16.00
- NMRA $1.45
- Analyst Decision
- MPAA
- NMRA Hold
- Analyst Count
- MPAA 0
- NMRA 8
- Target Price
- MPAA N/A
- NMRA $5.83
- AVG Volume (30 Days)
- MPAA 163.1K
- NMRA 376.8K
- Earning Date
- MPAA 11-11-2025
- NMRA 11-11-2025
- Dividend Yield
- MPAA N/A
- NMRA N/A
- EPS Growth
- MPAA N/A
- NMRA N/A
- EPS
- MPAA 0.08
- NMRA N/A
- Revenue
- MPAA $775,831,000.00
- NMRA N/A
- Revenue This Year
- MPAA $10.44
- NMRA N/A
- Revenue Next Year
- MPAA $4.88
- NMRA N/A
- P/E Ratio
- MPAA $200.82
- NMRA N/A
- Revenue Growth
- MPAA 6.59
- NMRA N/A
- 52 Week Low
- MPAA $5.16
- NMRA $0.61
- 52 Week High
- MPAA $16.59
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- MPAA 66.82
- NMRA 36.91
- Support Level
- MPAA $15.55
- NMRA $1.48
- Resistance Level
- MPAA $16.30
- NMRA $1.70
- Average True Range (ATR)
- MPAA 0.60
- NMRA 0.10
- MACD
- MPAA 0.05
- NMRA -0.03
- Stochastic Oscillator
- MPAA 75.21
- NMRA 7.21
About MPAA Motorcar Parts of America Inc.
Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.